| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2016PLoSO..1163353Y |
| P356 | DOI | 10.1371/JOURNAL.PONE.0163353 |
| P932 | PMC publication ID | 5082879 |
| P698 | PubMed publication ID | 27788148 |
| P50 | author | Laura Elnitski | Q30089923 |
| P2093 | author name string | Mary Qu Yang | |
| P2860 | cites work | BioGRID: a general repository for interaction datasets | Q24538650 |
| DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions | Q24548456 | ||
| Comprehensive molecular characterization of human colon and rectal cancer | Q24630415 | ||
| Mechanisms of disseminated cancer cell dormancy: an awakening field | Q27027015 | ||
| Integrated genomic analyses of ovarian carcinoma | Q27860518 | ||
| Cancer statistics, 2014 | Q27861018 | ||
| Network biology: understanding the cell's functional organization | Q27861027 | ||
| Activated PAK4 regulates cell adhesion and anchorage-independent growth | Q28213663 | ||
| The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data | Q28266682 | ||
| Rat toxicogenomic study reveals analytical consistency across microarray platforms | Q28270223 | ||
| Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy | Q28276600 | ||
| Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal | Q28288215 | ||
| Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids | Q28300710 | ||
| The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target | Q28305801 | ||
| The MIntAct project--IntAct as a common curation platform for 11 molecular interaction databases | Q28660703 | ||
| Lethality and centrality in protein networks | Q29547267 | ||
| Human Protein Reference Database--2009 update | Q29547392 | ||
| Evidence for dynamically organized modularity in the yeast protein-protein interaction network | Q29614449 | ||
| MAP kinase signalling pathways in cancer | Q29615542 | ||
| ROCR: visualizing classifier performance in R | Q29615821 | ||
| Network-based classification of breast cancer metastasis | Q29616384 | ||
| An integrative genomics approach to infer causal associations between gene expression and disease | Q29616385 | ||
| Integrative genomic profiling of human prostate cancer | Q29619905 | ||
| A travel guide to Cytoscape plugins | Q29788355 | ||
| Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome | Q33359495 | ||
| High-resolution analysis of copy number alterations and associated expression changes in ovarian tumors | Q33440056 | ||
| Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer | Q33511864 | ||
| The pak4 protein kinase plays a key role in cell survival and tumorigenesis in athymic mice | Q33656217 | ||
| The enigmatic effects of caffeine in cell cycle and cancer | Q33668772 | ||
| c-Myc target genes involved in cell growth, apoptosis, and metabolism | Q33956988 | ||
| A homozygous splicing mutation causing a depletion of skeletal muscle RYR1 is associated with multi-minicore disease congenital myopathy with ophthalmoplegia | Q44420417 | ||
| Alterations in the p53 pathway and prognosis in advanced ovarian cancer: a multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865). | Q44715114 | ||
| NCOR1 mRNA is an independent prognostic factor for breast cancer | Q46600184 | ||
| Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors | Q46641112 | ||
| Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary: a clinicopathologic analysis of 135 cases | Q47888032 | ||
| Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors. | Q50613227 | ||
| p53 DNA binding cooperativity is essential for apoptosis and tumor suppression in vivo. | Q51001724 | ||
| Combined analysis of p53 and RB pathways in epithelial ovarian cancer. | Q52544132 | ||
| RGS19 stimulates cell proliferation by deregulating cell cycle control and enhancing Akt signaling. | Q53237939 | ||
| NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma. | Q53257187 | ||
| Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary. | Q53609842 | ||
| Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers | Q55554493 | ||
| The Evolutionary Rate of a Protein Is Influenced by Features of the Interacting Partners | Q57772817 | ||
| Validating the impact of a molecular subtype in ovarian cancer on outcomes: A study of the OVCAD Consortium | Q61853673 | ||
| Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer | Q73803404 | ||
| Secretion of vascular endothelial growth factor in ovarian cancer | Q78014435 | ||
| Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma | Q79825860 | ||
| Grading ovarian serous carcinoma using a two-tier system | Q79934949 | ||
| Performance comparison of one-color and two-color platforms within the MicroArray Quality Control (MAQC) project | Q80238189 | ||
| Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma | Q80340138 | ||
| Gene expression signature with independent prognostic significance in epithelial ovarian cancer | Q80908361 | ||
| Error and attack tolerance of layered complex networks | Q81424767 | ||
| Network-based prediction of human tissue-specific metabolism | Q81798711 | ||
| Aberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells | Q34000057 | ||
| Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary | Q34103978 | ||
| Trends in the exploitation of novel drug targets | Q34205159 | ||
| MINT, the molecular interaction database: 2012 update | Q34233947 | ||
| Broker genes in human disease | Q34334459 | ||
| TGF-beta induces serous borderline ovarian tumor cell invasion by activating EMT but triggers apoptosis in low-grade serous ovarian carcinoma cells. | Q34384395 | ||
| Reconstruction of cellular signalling networks and analysis of their properties | Q34385115 | ||
| The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis | Q34641759 | ||
| Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer | Q34652960 | ||
| Functional Analysis of Novel Analogues of E3330 That Block the Redox Signaling Activity of the Multifunctional AP Endonuclease/Redox Signaling Enzyme APE1/Ref-1 | Q34700214 | ||
| Using protein complexes to predict phenotypic effects of gene mutation | Q34718634 | ||
| Dynamic modularity in protein interaction networks predicts breast cancer outcome | Q34934057 | ||
| Modeling high-grade serous ovarian carcinogenesis from the fallopian tube | Q34938333 | ||
| The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer | Q34984679 | ||
| A unique four-hub protein cluster associates to glioblastoma progression. | Q35210961 | ||
| BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group | Q36145443 | ||
| Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo | Q36328579 | ||
| Initial report on differential expression of sprouty proteins 1 and 2 in human epithelial ovarian cancer cell lines | Q36454937 | ||
| Src activation by β-adrenoreceptors is a key switch for tumour metastasis. | Q36579843 | ||
| The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer | Q36785983 | ||
| Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma | Q36898398 | ||
| Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas. | Q37080992 | ||
| TGF-β modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment. | Q37100262 | ||
| Defining the cut point between low-grade and high-grade ovarian serous carcinomas: a clinicopathologic and molecular genetic analysis | Q37276915 | ||
| Elevated NCOR1 disrupts a network of dietary-sensing nuclear receptors in bladder cancer cells | Q37292722 | ||
| An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors | Q37294205 | ||
| Apoptotic signaling by c-MYC. | Q37310199 | ||
| Phosphorylation-acetylation switch in the regulation of STAT1 signaling | Q37625138 | ||
| Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis | Q37903701 | ||
| Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type | Q39012911 | ||
| A phosphorylation-acetylation switch regulates STAT1 signaling | Q39890532 | ||
| ERK-dependent MKP-1-mediated cisplatin resistance in human ovarian cancer cells | Q40033516 | ||
| Consequences of direct versus indirect activation of epidermal growth factor receptor in intestinal epithelial cells are dictated by protein-tyrosine phosphatase 1B. | Q40163127 | ||
| Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling | Q40444417 | ||
| TCDD-induced homologous recombination: the role of the Ah receptor versus oxidative DNA damage | Q40523278 | ||
| Inactivation of the mitogen-activated protein kinase pathway as a potential target-based therapy in ovarian serous tumors with KRAS or BRAF mutations | Q42801833 | ||
| Tissue specificity and the human protein interaction network | Q43125316 | ||
| P275 | copyright license | Creative Commons CC0 License | Q6938433 |
| P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | protein-protein interaction | Q896177 |
| ovarian cancer | Q172341 | ||
| systems biology | Q815297 | ||
| P304 | page(s) | e0163353 | |
| P577 | publication date | 2016-10-27 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | A Systems Biology Comparison of Ovarian Cancers Implicates Putative Somatic Driver Mutations through Protein-Protein Interaction Models | |
| P478 | volume | 11 |
| Q58738631 | Transcriptomic and genomic profiling of early-stage ovarian carcinomas associated with histotype and overall survival | cites work | P2860 |
Search more.